Effectiveness Study of Nivolumab Compared to Placebo in Prevention of Recurrent Melanoma After Complete Resection of Stage IIB/C Melanoma
ACTIVE_NOT_RECRUITING
Status
Conditions
Interventions
- BIOLOGICAL: Nivolumab
- OTHER: Placebo
Sponsor
Bristol-Myers Squibb